These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2937394)

  • 21. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.
    Murialdo G; Galimberti CA; Magri F; Sampaolo P; Copello F; Gianelli MV; Gazzerro E; Rollero A; Deagatone C; Manni R; Ferrari E; Polleri A; Tartara A
    J Endocrinol Invest; 1997 Oct; 20(9):519-26. PubMed ID: 9413805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive dysfunction in women with epilepsy.
    Isojärvi JI
    Neurology; 2003 Sep; 61(6 Suppl 2):S27-34. PubMed ID: 14504307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive endocrine considerations and hormonal therapy for women with epilepsy.
    Herzog AG
    Epilepsia; 1991; 32 Suppl 6():S27-33. PubMed ID: 1959509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy.
    Bauer J; Blumenthal S; Reuber M; Stoffel-Wagner B
    Neurology; 2004 Jan; 62(2):243-6. PubMed ID: 14745061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The monocystic ovary syndrome.
    Delahunt JW; Clements RV; Ramsay ID; Newton J; Collins WP; Landon J
    Br Med J; 1975 Dec; 4(5997):621-2. PubMed ID: 1203702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine dysfunction in temporal lobe epilepsy.
    Herzog AG; Russell V; Vaitukaitis JL; Geschwind N
    Arch Neurol; 1982 Mar; 39(3):133-5. PubMed ID: 7039563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
    Cantor B; Kalra PS; Buhi WC; Birk SA; Spellacy WN
    Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles.
    Abdel Gadir A; Khatim MS; Mowafi RS; Alnaser HM; Muharib NS; Shaw RW
    Hum Reprod; 1992 Apr; 7(4):453-7. PubMed ID: 1522185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone concentrations in female athletes and ballet dancers with menstrual disorders.
    Łagowska K; Kapczuk K
    Eur J Sport Sci; 2016; 16(4):490-7. PubMed ID: 25951882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
    Noldus J; Huland H
    Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
    McPherson JC; Costoff A; Mahesh VB
    Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired prolactin response to thyrotropin-releasing hormone in isolated gonadotropin deficiency and exaggerated response in primary testicular failure.
    Spitz IM; Zylber E; Cohen H; Almaliach U; Leroith D
    J Clin Endocrinol Metab; 1979 Jun; 48(6):941-5. PubMed ID: 109459
    [No Abstract]   [Full Text] [Related]  

  • 40. Human sexuality, sex hormones, and epilepsy.
    Morris GL; Vanderkolk C
    Epilepsy Behav; 2005 Dec; 7 Suppl 2():S22-8. PubMed ID: 16243001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.